PharmaSGP achieved revenues of around 65 million in the financial year 2021, reaching the upper end of the published guidance ( 60 million to 65 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 EUR | -0.87% | -0.87% | +1.33% |
04-29 | PharmaSGP Holding SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.33% | 297M | |
+31.06% | 695B | |
+26.51% | 568B | |
-4.61% | 361B | |
+19.70% | 330B | |
+3.76% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.91% | 168B |
- Stock Market
- Equities
- PSG Stock
- News PharmaSGP Holding SE
- PharmaSGP Announces Revenue Results for the Financial Year 2021